QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Real-world evidence (RWE) and Clinical Trials: Complementary roles in evidence- based research for all patients
Certain patient groups may be underrepresented or excluded from RCTs due to eligibility criteria, logistical barriers, ethical concerns or other reasons.
Examples of these potential groups are females, pregnant or breastfeeding females, older adults due to age or comorbidities, children, people with rare or orphan diseases, people from underserved or minority communities, non-binary or transgender individuals, people with mental health disorders, and people on polypharmacy.
RWE studies provide opportunities to derive […]
Quantify is excited to announce that it has joined the Athagoras group
ATHAGORAS Holding GmbH is building a group of leading service providers to create a tech-enabled European specialist service provider for the clinical and commercial development of healthcare innovations in the pharmaceutical & biotech industry within regulatory affairs, pharmacovigilance, as well as market access and real-world evidence.
Quantify Research and Athagoras are highly aligned in vision and commitment to client excellence. This partnership ensures that our clients will benefit from […]
Tune in to Monsenso´s webinar on Patient-Centricity in Decentralised Trials next Wednesday!
Quantify Research‘s very own Mary Rosenzweig will join speakers from Monsenso, Lundbeck and Copenhagen Institute for Futures Studies in sharing their expertise on how real-world data can transform clinical trials.
Don’t miss this opportunity to stay ahead in […]
✨Happy new Year!✨
The Quantify Research team are back and ready to get into in the swing of things following our Christmas break.
With fresh New Years Resolutions at the ready we look forward to catching up with clients and colleagues and start off 2025 with new exciting projects!
What New Years Resolutions have you got for the year ahead?
